{"id":"https://openalex.org/W3137984521","doi":"https://doi.org/10.1159/000514535","title":"Biological Therapies for Atopic Dermatitis: A Systematic Review","display_name":"Biological Therapies for Atopic Dermatitis: A Systematic Review","alternate_titles":[],"publication_year":2021,"publication_date":"2021-03-18","ids":{"openalex":"https://openalex.org/W3137984521","doi":"https://doi.org/10.1159/000514535","mag":"3137984521","pmid":"https://pubmed.ncbi.nlm.nih.gov/33735876"},"language":"en","primary_location":{"id":"doi:10.1159/000514535","doi":"https://doi.org/10.1159/000514535","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000514535","pdf_url":null,"source":{"id":"https://openalex.org/S135397728","display_name":"Dermatology","issn_l":"1018-8665","issn":["1018-8665","1421-9832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3137984521"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010547642","display_name":"Shuying Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shuying Zhou","raw_affiliation_strings":["Department of Dermatology, The 305 Hospital of PLA, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, The 305 Hospital of PLA, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101684213","display_name":"Fei Qi","orcid":"https://orcid.org/0000-0002-8635-2810","observed_orcids":["https://orcid.org/0000-0002-8635-2810"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fei Qi","raw_affiliation_strings":["Capital Medical University Affiliated with Beijing Chaoyang Hospital, Beijing, China, qifeiphaedra@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Capital Medical University Affiliated with Beijing Chaoyang Hospital, Beijing, China, qifeiphaedra@gmail.com","institution_ids":["https://openalex.org/I183519381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065675807","display_name":"Yue Gong","orcid":"https://orcid.org/0000-0002-6842-5318","observed_orcids":["https://orcid.org/0000-0002-6842-5318","https://orcid.org/0009-0009-3824-3300"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yue Gong","raw_affiliation_strings":["Department of Dermatology, The 305 Hospital of PLA, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, The 305 Hospital of PLA, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113849491","display_name":"Jinping Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jinping Zhang","raw_affiliation_strings":["Department of Dermatology, The 305 Hospital of PLA, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, The 305 Hospital of PLA, Beijing, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102020536","display_name":"Binghua Zhu","orcid":"https://orcid.org/0000-0002-7637-0230","observed_orcids":["https://orcid.org/0000-0002-7637-0230"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Binghua Zhu","raw_affiliation_strings":["Department of Dermatology, The 305 Hospital of PLA, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, The 305 Hospital of PLA, Beijing, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7053,"has_fulltext":true,"cited_by_count":62,"citation_normalized_percentile":{"value":0.85083799,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"237","issue":"4","first_page":"542","last_page":"552"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":1.0},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/dupilumab","display_name":"dupilumab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/baricitinib","display_name":"baricitinib","score":0.871999979019165},{"id":"https://openalex.org/keywords/abrocitinib","display_name":"abrocitinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/delgocitinib","display_name":"delgocitinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nemolizumab","display_name":"nemolizumab","score":0.9039999842643738},{"id":"https://openalex.org/keywords/anti-il-13-antibody","display_name":"anti-IL-13 antibody","score":0.8939999938011169},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.578000009059906},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.7995831370353699},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6856586933135986},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6336987614631653}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000514535","doi":"https://doi.org/10.1159/000514535","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000514535","pdf_url":null,"source":{"id":"https://openalex.org/S135397728","display_name":"Dermatology","issn_l":"1018-8665","issn":["1018-8665","1421-9832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology","raw_type":"journal-article"},{"id":"pmid:33735876","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33735876","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology (Basel, Switzerland)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":75,"referenced_works":["https://openalex.org/W980174965","https://openalex.org/W1578008264","https://openalex.org/W1592334036","https://openalex.org/W1630159102","https://openalex.org/W1892175722","https://openalex.org/W1965217362","https://openalex.org/W1966518661","https://openalex.org/W1975165863","https://openalex.org/W1980040943","https://openalex.org/W1988011157","https://openalex.org/W1992025888","https://openalex.org/W1999218213","https://openalex.org/W2002600662","https://openalex.org/W2012868073","https://openalex.org/W2015091308","https://openalex.org/W2018126926","https://openalex.org/W2018916159","https://openalex.org/W2021520444","https://openalex.org/W2027164200","https://openalex.org/W2028648418","https://openalex.org/W2045189254","https://openalex.org/W2071435594","https://openalex.org/W2086221920","https://openalex.org/W2090399555","https://openalex.org/W2095224028","https://openalex.org/W2118630839","https://openalex.org/W2130509509","https://openalex.org/W2136267701","https://openalex.org/W2138647255","https://openalex.org/W2149189075","https://openalex.org/W2165235005","https://openalex.org/W2167305078","https://openalex.org/W2312279372","https://openalex.org/W2343661135","https://openalex.org/W2408019941","https://openalex.org/W2419000811","https://openalex.org/W2465799764","https://openalex.org/W2468996569","https://openalex.org/W2549727139","https://openalex.org/W2593200577","https://openalex.org/W2598094671","https://openalex.org/W2607449794","https://openalex.org/W2752706812","https://openalex.org/W2772574494","https://openalex.org/W2783616522","https://openalex.org/W2783829013","https://openalex.org/W2784010902","https://openalex.org/W2787696154","https://openalex.org/W2789024274","https://openalex.org/W2807789068","https://openalex.org/W2888816848","https://openalex.org/W2901678825","https://openalex.org/W2904772462","https://openalex.org/W2911254450","https://openalex.org/W2913106255","https://openalex.org/W2948249774","https://openalex.org/W2965009353","https://openalex.org/W2967103828","https://openalex.org/W2969960972","https://openalex.org/W2978096514","https://openalex.org/W2979421310","https://openalex.org/W2979884851","https://openalex.org/W2981004305","https://openalex.org/W2981702922","https://openalex.org/W2991540591","https://openalex.org/W2993335231","https://openalex.org/W2996140352","https://openalex.org/W3004398344","https://openalex.org/W3008661668","https://openalex.org/W3016966216","https://openalex.org/W3032018657","https://openalex.org/W3033256694","https://openalex.org/W3044651017","https://openalex.org/W3087781368","https://openalex.org/W4211013257"],"related_works":["https://openalex.org/W3134137987","https://openalex.org/W4400446896","https://openalex.org/W7212313198","https://openalex.org/W4412955741","https://openalex.org/W2765823142","https://openalex.org/W4414452325","https://openalex.org/W2890387717","https://openalex.org/W7125925186","https://openalex.org/W7101391470","https://openalex.org/W4294128272"],"abstract_inverted_index":{"BACKGROUND:":[0],"Atopic":[1],"dermatitis":[2],"(AD)":[3],"is":[4],"a":[5,56,127],"widely":[6,15,185],"acquired,":[7],"relapsing":[8],"inflammatory":[9],"skin":[10],"disease.":[11],"Biologics":[12],"are":[13],"now":[14],"used":[16,186],"in":[17,36,105,109,178,192,204,257,308],"patients":[18,323],"with":[19,83,90,234,275,284],"moderate-to-severe":[20,273],"AD.":[21,72,243],"OBJECTIVE:":[22],"This":[23,317],"work":[24],"aims":[25],"to":[26,65,78],"summarize":[27],"both":[28,205],"label":[29],"and":[30,39,43,63,119,124,149,174,187,195,202,207,278,291,301,328],"off-label":[31],"biologics":[32,306],"on":[33,46,80,242,289],"AD":[34,89,274,295],"treatment":[35,296],"phase":[37,40,223,259],"II":[38],"III":[41],"stages,":[42],"compile":[44],"evidence":[45,86,236,288],"the":[47,50,84,183,258,285,305,314],"efficacy":[48,290],"of":[49,154,229,254,304],"most-studied":[51],"biologics.":[52],"METHODS:":[53],"We":[54,137],"conducted":[55],"comprehensive":[57],"literature":[58],"search":[59],"through":[60],"PubMed,":[61],"EMBASE,":[62],"ClinicalTrials.gov":[64],"identify":[66],"all":[67,218,253],"documented":[68],"biological":[69,282,326],"therapies":[70,283,327],"for":[71,88,248,272,294,333],"The":[73,281],"criteria":[74],"were":[75,107,130,135,176,217,232,245,256,311],"further":[76],"refined":[77],"focus":[79],"those":[81],"treatments":[82],"highest":[85],"level":[87],"at":[91,222,313],"least":[92],"one":[93],"randomized":[94,140],"clinical":[95,220,261],"trial":[96,262],"supporting":[97],"their":[98,238],"use.":[99],"Only":[100,132],"studies":[101],"or":[102],"articles":[103,118,123],"published":[104],"English":[106],"enrolled":[108],"this":[110,179,309],"study.":[111],"FINDINGS:":[112],"Primary":[113],"searches":[114],"identified":[115],"525":[116],"relevant":[117],"27":[120],"trials.":[121],"Duplicated":[122],"papers":[125],"without":[126],"full":[128],"text":[129],"excluded.":[131],"completed":[133],"trials":[134,197,221,247],"enrolled.":[136],"included":[138,177],"28":[139],"controlled":[141],"trials,":[142,145],"4":[143,196],"unpublished":[144],"2":[146,260],"observational":[147],"studies,":[148],"1":[150,193],"meta-analysis.":[151],"Eight":[152],"kinds":[153,228],"biologics,":[155],"including":[156],"IL-4/IL-13":[157,214],"inhibitors,":[158,160],"JAK":[159,230],"anti-IL-13":[161,251],"antibodies,":[162,164,166,173],"anti-IL-22":[163],"anti-IL-33":[165],"thymic":[167],"stromal":[168],"lymphopoietin":[169],"inhibitor":[170],"(TSLP),":[171],"OX40":[172],"H4R-antagonists":[175],"work.":[180],"Dupliumab,":[181],"as":[182],"most":[184,286],"investigated":[188],"biologic,":[189],"was":[190],"reported":[191],"meta-analysis":[194],"exploring":[198],"its":[199],"long-term":[200,276,292],"use":[201],"application":[203],"adults":[206],"pediatric":[208],"patients.":[209],"Besides":[210],"dupilumab,":[211,298],"four":[212],"other":[213],"inhibitors":[215,231],"recruited":[216],"randomized,":[219],"2-3":[224],"stage.":[225,263,316],"Six":[226],"different":[227],"summarized":[233],"strong":[235],"revealing":[237],"significant":[239],"therapeutic":[240],"effects":[241],"There":[244],"3":[246],"nemolizumab,":[249],"an":[250],"antibody,":[252],"which":[255],"Results":[264],"showed":[265],"nemolizumab":[266],"could":[267],"be":[268],"another":[269],"alternative":[270],"therapy":[271],"efficiency":[277],"safety.":[279],"CONCLUSION:":[280],"robust":[287],"safety":[293],"include":[297],"barcitinib,":[299],"abrocitinib,":[300],"delgocitinib.":[302],"Most":[303],"mentioned":[307],"review":[310,318],"still":[312],"exploratory":[315],"will":[319],"help":[320],"practitioners":[321],"advise":[322],"seeking":[324],"suitable":[325],"offer":[329],"experimental":[330],"study":[331],"directions":[332],"treatment.":[334]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3137984521","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2021-03-29T00:00:00"}
